6Tuder RM,Cool CD,Geraci MW,et al.Prostacyclin synthase expression is decreased inhngs from patients with severe pulmonary hypertension.Am J Respir Crit Care Med,1999,159:1925-1932.
7Giaid A,Yanagisawa M,Langleben D,et al.Expression of endobethelin-1 in the lungs of patients with pulmonary hypertension.N EnglJ Med,1993,328:1732-1739.
8Clapp LH,Finney P,Turcato S,et al.Differentialeffects of stable prostacyclin analogues on smooth muscle proliferation andcyclic AMP generation in human pulmonary artery.Am J RespirCell Mol Biul,2002,26:194-201.
10Schermuly RT,Inhulte C,Ghofrani HA,et al.Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension:amplification by different type phosphodiesterase inhibitors.Respir Res,2005,6:76.
2Thistlethwaite PA, Mo M, Madani MM, et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg, 2002,124: 1203-1211.
7Reichenberger F, Voswinckel R, Enke B, et al. long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J,2007,30:922-927.
8Bresser P, Pepke-Zaba J, Jais X, et al. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm. Proc Am Thorac Soc ,2006, 3:594-600.
9Huges R j, Jais X, Bonderman D, et al. The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study. Eur Respir J,2006, 28 : 138-143.
7Leuchte HH,Schwaiblmair M,Baumgartner RA,et al.Hemodynamic response to sildenafil,nitric oxide,and ilopmst in primary pulmonary hypertension.Chest,2004,125:580-586.
8Ghofrani HA,Rose F,Sehermuly RT,et al.Oral sildenafil as long-term adjunct therapy to inhaled iloprost in seveFe pulmonary arterial hypertension.J Am Coll Cardiol,2003,42:158-164.
9Mikhail GW,Prasad SK,L iW,et al.Clinical and haemodynamic effects of sildenafil in pulmonary hypertension:acute and mid-term effectsl.Eur Heart J,2004,25:431-436.
10Sastry BK,Narasimhan C,Reddy NK,et al.Clinical efficacy of sildenafil in primary pulmonary hypertension:a randomized,plaeebo-controlled,double-blind,crossover tudy.J Am Coil Cardiol,2004,43:1149-1153.
